BTMD — biote Corp.

Nasdaq · Materials · Chemicals · CIK 1819253 ·
Last close
$1.92
Market Cap
$58.24M
52W High
$2.33
52W Low
$1.27
ADV30
210,667
Next earnings
2026-08-05
biote Corp. operates in practice-building business within the hormone optimization space. It trains physicians and nurse practitioners in hormone optimization using bioidentical hormone replacement pellet therapy in men and women experiencing hormonal imbalance. The company offers Biote Method, a comprehensive end-to-end practice building platform that provides Biote-certified practitioners with the components developed for practitioners in the hormone optimization space comprising Biote Method education, training, and certification; practice management software that allows Biote-certified practitioners to order, track, and manage hormone optimization product inventory and meet other administrative requirements; inventory management software to facilitate ordering and inventory control; and information regarding available hormone replacement therapy products, as well as digital and point-of-care marketing support. It also sells dietary supplements under the Biote brand; and sterile pellet insertion kits that is used with hormone optimization therapies for male and female patients. The company was founded in 2012 and is headquartered in Irving, Texas.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Mar 2026 44,935,000 30,953,000 3,166,000 2,277,000 89,032,000 5,320,000 136,987,000
Dec 2025 46,408,000 31,573,000 6,829,000 1,954,000 107,613,000 24,123,000 158,010,000
Sep 2025 47,956,000 34,418,000 8,267,000 8,188,000 111,324,000 28,048,000 176,791,000
Jun 2025 48,863,000 34,988,000 10,765,000 3,185,000 104,798,000 19,601,000 183,638,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$35,194,000
Investing CF
$-6,864,000
Financing CF
$-43,555,000
CapEx
$-6,864,000
Dividends Paid
$-1,727,000
Buybacks
$-3,365,000
EPS Diluted TTM
$0.75
As of
2026-05-10

Balance + Analyst (yfinance extras)

Retained Earnings
$-49,549,000
Inventory
$19,064,000
Receivables
$7,677,000
ST Investments
EBIT TTM
$48,545,000
Pretax Income TTM
$37,584,000
Interest Exp TTM
$10,961,000
Analysts
5

Yahoo Snapshot (yfinance, live)

Total Revenue
$188,162,000
EBITDA
$32,858,000
Free Cash Flow
$-4,732,875
Enterprise Value
$171,597,536
Total Cash
$5,320,000
Total Debt
$108,422,000
Shares Out
30,331,425
Trailing EPS
$0.43
Book Value
$-1.87
ROE
ROA
17.8%
Div Yield

Annual Trend (SEC EDGAR, last 5y)

Revenues vs Net Income (last 5y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Dec 2025 192,219,000 35,551,000 27,045,000 107,613,000 158,010,000 35,194,000
Dec 2024 197,191,000 31,611,000 3,157,000 122,370,000 224,570,000 45,243,000
Dec 2023 185,360,000 28,657,000 3,316,000 155,295,000 191,841,000 26,883,000
Dec 2022 164,957,000 -60,722,000 -969,000 111,645,000 169,919,000 -9,157,000
Dec 2021

TTM Snapshot

Revenues TTM
NetIncome TTM
OpCashFlow TTM
Assets (Latest)
Forward EPS
$0.57

Peers — same industry

TickerNameMarket CapLastDaily %
TLGYF TLGY ACQUISITION CORP $64.03M $11.00
ZTEK Zentek Ltd. $64.42M $0.60
LOOP Loop Industries, Inc. $67.19M $1.39
AXIL Axil Brands, Inc. $47.86M $7.02
CHUC Charlie's Holdings, Inc. $71.29M $0.26

News headlines (Yahoo Finance, 1h cache)

biote Corp. Q1 2026 Earnings Call Summary
2026-05-07 12:30 · Yahoo
biote Q1 Earnings Call Highlights
2026-05-06 23:35 · Yahoo
biote Corp. (BTMD) Q1 Earnings and Revenues Lag Estimates
2026-05-06 22:30 · Yahoo
Biote Reports First Quarter 2026 Financial Results
2026-05-06 20:05 · Yahoo
How The biote (BTMD) Narrative Is Shifting As Targets Tighten And Guidance Holds
2026-05-02 19:16 · Yahoo
GE HealthCare Technologies (GEHC) Lags Q1 Earnings Estimates
2026-04-29 11:45 · Yahoo
Biote Schedules First Quarter 2026 Financial Results Release and Conference Call
2026-04-22 20:05 · Yahoo
How The Investment Story For Biote (BTMD) Is Shifting With Reset Expectations And 2026 Guidance
2026-04-04 17:08 · Yahoo
Biote Corp (BTMD) Q4 2025 Earnings Call Highlights: Strategic Growth Amid Revenue Challenges
2026-03-12 03:00 · Yahoo
biote Corp. Q4 2025 Earnings Call Summary
2026-03-12 00:15 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.